Benzinga | Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals

Market Overview

0.0000 0 (%)

Data as of Dec 09, 2019

Prev. Close
Price Open
Volume 0
Day's Range -
52 Wk Range -
50 Day Moving Avg.
PE Ratio
Shares Outstanding
Market Cap

Trade EDT stock with recommended broker Ally Invest. Commissions as low as $3.95.

Analyst Rating View All Ratings

Financial Breakfast: Morning News Summary for June 4, 2012 Brandon PilznerMon, 04 Jun 2012 06:25:43 -0500
Transocean Launches Unconditional Offer for Shares of Aker Drilling Eddie StaleyFri, 26 Aug 2011 05:54:15 -0500
Oilsands Quest Inc. Extends Rights Offering Subscription Period Allie WickmanWed, 10 Aug 2011 07:01:24 -0500
Bank of America Expects Greater Earnings on Alkemes Inc. from Approval of Bydureon, Mantains Buy Bo WangThu, 23 Jun 2011 17:52:08 -0500
UPDATE: Hapoalim Raising Price Target On Alkermes (ALKS) Jonathan ChenMon, 09 May 2011 11:38:37 -0500
{{ story.title }} {{ story.author }}{{ story.created }}

NCR Announces Strong First-Quarter Results Benzinga StaffApr 19, 2012
Sprint Gives Customers Incentives to Go Green on Earth Day Benzinga StaffApr 19, 2012
Sprint Gives Customers Incentives to Go Green on Earth Day Benzinga StaffApr 19, 2012
Staples.com Survey Reveals Businesses Can Manage Without the Boss, But Not the Office Administrator Benzinga StaffApr 19, 2012
Webcast Alert: Heska Corporation's Annual Meeting of Stockholders Webcast PRWebApr 19, 2012
Syntel Reports First Quarter 2012 Financial Results Benzinga StaffApr 19, 2012
Boston Scientific Announces First Quarter 2012 Results PRWebApr 19, 2012
Maxwell Technologies to Report First Quarter Financial Results on April 26; Annual Stockholders Meeting Set for May 9 PRWebApr 19, 2012
Nexon to Release First Quarter 2012 Financial Results Benzinga StaffApr 19, 2012
Crown Holdings Reports First Quarter 2012 Results PRWebApr 18, 2012
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Christopher Browne: Finding the Silver Lining When Markets Dip GuruFocusJun 05, 2019
Will Uranium Ever Be a Buy? GuruFocusAug 29, 2016
Spectral Announces Normal Course Issuer Bid GuruFocusJul 04, 2016
FDA Accepts Spectral's Expanded Access Protocol for Toraymyxin(TM) GuruFocusJun 27, 2016
Spectral Medical Announces Acceptance of Pre-Clinical PMA Module for Toraymyxin(TM) by FDA GuruFocusJun 16, 2016
Spectral Commends Inclusion of Organ Dysfunction in New Expert Consensus Definitions of Sepsis ... GuruFocusMar 07, 2016
Spectral Approaches Finish Line for Clinical and Regulatory Program GuruFocusMar 01, 2016
Spectral and Toray Medical Sign Exclusive EAA(TM) Distribution Agreement for 15 Countries in ... GuruFocusOct 21, 2015
Body of Evidence Supporting the Use of Toraymyxin(TM) for Treatment of Septic Shock Continues ... GuruFocusOct 19, 2015
Spectral Now Recruiting the Last 75 Patients in Its Phase III Trial GuruFocusSep 14, 2015
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Earnings View Earnings

Q3 2019	EST	Actual	Surprise
EPS:	Expected 2019-11-14
Rev:	Expected 2019-11-14

Q4 2019	EST	Actual	Surprise
EPS:	Expected 2020-02-02
Rev:	Expected 2020-02-02

Brokerage Center

Compare All Online Brokerages

Book A Demo

Learn How You Can Succeed In The Market With Benzinga Pro

Fastest Market News

Real-Time News Alerts

Customizable News Filters

Book A Demo